RT Journal Article SR Electronic T1 Are Suboptimal in utero Conditions Associated with Obesity and Cardiometabolic Risk Factors in Caucasian children? JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.18.20132837 DO 10.1101/2020.06.18.20132837 A1 Soraya Saidj A1 Melanie Henderson A1 Stephanie-May Ruchat A1 Gilles Paradis A1 Andraea Van Hulst A1 Michael Zappitelli A1 Marie-Eve Mathieu YR 2020 UL http://medrxiv.org/content/early/2020/07/29/2020.06.18.20132837.abstract AB Objective To explore the association between in utero exposure to suboptimal gestational factors (SGFS; gestational diabetes mellitus, hypertensive disorders during pregnancy, maternal smoking during pregnancy), childhood obesity, and cardiometabolic risk factors.Methods Data were obtained from the “QUebec Adiposity and Lifestyle InvesTigation in Youth” longitudinal study (QUALITY) composed of 630 Caucasian children recruited at age 8–10 (first visit V1; n=619) and followed-up 2 years later (second visit V2; n=557). Multivariate logistic regression models were used.Results In the cohort, maternal smoking during pregnancy was associated with higher odds of obesity (OR1=2.00, 95% CI 1.25-3.20, OR2=2.29, 95% CI 1.26-4.16) at both visit and with higher odds of high waist circumference (OR1=1.96, 95% CI 1.24-3.1) at V1. Hypertensive disorders during pregnancy were associated with higher odds of obesity (OR1=2.37, 95% CI 1.17-4.80) at visit 1. Joint exposure to SGFS was associated with higher odds of: high waist circumference (OR1=1.42, 95% CI 1.06-1.91) at V1, obesity (OR2= 1.63, 95% CI 1.153-2.32) at V2 and low levels of HDL cholesterol (OR2=1.45, 95% CI 1.04-2.03) at V2. Analysis stratification by sex revealed that boys were more adversely affected by exposure to combined SGFS while girls were more affected by exposure to maternal smoking during pregnancy.Conclusion In utero exposure to an independent or combined SGFS is associated with adverse adipose and cardiometabolic profiles in children, with sex specificities.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThe QUALITY cohort is funded by the Canadian Institutes of Health Research (#OHF-69,442, #NMD-94,067, #MOP-97,853, #MOP-119,512), the Heart and Stroke Foundation of Canada (#PG-040291) and Fonds de la Recherche en Sante du Quebec. Melanie Henderson and Marie-Eve Mathieu respectively hold Fonds de Recherche en Sante du Quebec Junior 2 and 1 salary awards.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The QUALITY study was approved by the Ethics Review Boards of the Sainte-Justine University Hospital Center and Quebec Heart and Lung Institute.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not available.